Drug makers are going beyond continuous improvement and green chemistry to increase the sustainability of small-molecule manufacturing. In the latest Intergovernmental Panel on Climate Change report ...
India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
Industry leaders say the inclusion of 77 raw materials under new or expanded duty concessions will help reduce procurement ...
Saneca Pharma is making significant investment in its API capabilities to support client demand for smaller batch sizes and streamlined scale-up. Slovakia-based CDMO Saneca Pharma announced that it is ...
10don MSNOpinion
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME Day
Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations.
BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and ...
Indian drugmaker Mankind Pharma intends to add an active pharmaceutical ingredient (API) manufacturing facility to its network of 16 production plants in India. The company says it will invest about ...
Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...
Cadila Pharmaceuticals inaugurated a Rs. 200 crore API plant in Dahej. The plant, equipped with advanced DCS automation technology, aims to enhance pharmaceutical production. The facility is designed ...
BROOKLYN, New York, Oct. 14, 2020 (GLOBE NEWSWIRE) -- According to Global Market Estimates, the Indian API Market will grow rapidly at a CAGR of 8.57% during the 2020-2026 phase. The Indian drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results